Contineum Therapeutics (CTNM) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 26, 2026, to be held virtually for stockholders of record as of April 27, 2026.

• Proxy materials and annual report are available online, with options to request paper or email copies by June 16, 2026.

Voting matters and shareholder proposals

• Election of three Class II directors to serve until the 2029 annual meeting or until successors are appointed.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Provision to conduct any other business properly brought before the meeting or adjournment.

Board of directors and corporate governance

• Nominees for Class II director positions are Evert Schimmel Pennink, Lori M. Lyons-Williams, and Diego Miralles, M.D.